Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans

@article{Weng2012QuercetinIM,
  title={Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans},
  author={Zuyi Weng and B. Zhang and Shahrzad Asadi and Nikolaos Sismanopoulos and Alan Butcher and Xueyan Fu and Alexandra Katsarou-Katsari and Christina Antoniou and Theoharis C. Theoharides},
  journal={PLoS ONE},
  year={2012},
  volume={7}
}
Mast cells are immune cells critical in the pathogenesis of allergic, but also inflammatory and autoimmune diseases through release of many pro-inflammatory cytokines such as IL-8 and TNF. [] Key Result Que and cromolyn (100 µM) can effectively inhibit secretion of histamine and PGD(2).

Figures from this paper

The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
Impact of polyphenols on mast cells with special emphasis on the effect of quercetin and luteolin
TLDR
The interrelationship between mast cells and polyphenols is reported for the first time and has a negative effect on FceRI cross-linking and other activating receptors on mast cells.
Quercetin and Its Anti-Allergic Immune Response
TLDR
Plant extract of quercetin is the main ingredient of many potential anti- allergic drugs, supplements and enriched products, which is more competent in inhibiting of IL-8 than cromolyn (anti-allergic drug disodium cromoglycate) and suppresses IL-6 and cytosolic calcium level increase.
Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells
TLDR
Findings indicate that mTOR is partially involved in the neuropeptide stimulation of MCs, but the novel flavonoid methoxyluteolin inhibits the response entirely, suggesting that it may be developed for treatment of allergic and inflammatory diseases.
The inhibitory effects of flavonoids on chemokine function in allergic asthma and food allergy
TLDR
Although the exact mechanism behind flavonoid inhibitory effects remains unclear, administration of flavonoids seems to be a promising dietary treatment for allergic asthma and food allergy.
Luteolin Inhibits Human Keratinocyte Activation and Decreases NF-κB Induction That Is Increased in Psoriatic Skin
TLDR
Psoriasis is an autoimmune disease characterized by keratinocyte hyperproliferation and chronic inflammation, with increased expression of tumor necrosis factor and vascular endothelial growth factor, and flavonoid luteolin significantly inhibits mRNA expression and release of all three mediators in a concentration-dependent manner.
Mast cell and eosinophil surface receptors as targets for anti‐allergic therapy
Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion
TLDR
The use of this tetramethoxyluteolin formulation resulted in significant improvement of the skin lesions and could be useful adjuvant treatment for allergic and inflammatory skin conditions.
The role of human mast cells in allergy and asthma
TLDR
This review aims to update the existing knowledge on the mediators released by human FcεRI-activated mast cells, and to unravel their pathological and protective roles in asthma and allergy.
Role of TNF Alpha, IL-33 and CCL2/MCP-1 in Mast Cell Activity
TLDR
It is reported that IL-33 is a strong activator of human mast cell capable to induce CCL2/MCP-1 released at translational level, suggesting that this cytokine may have an important effect on the recruitment of inflammatory cells in allergic diseases.
...
...

References

SHOWING 1-10 OF 99 REFERENCES
IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skin
TLDR
The results imply that functional interactions among SP, IL-33, and mast cells leading to VEGF release contribute to inflammatory conditions, such as the psoriasis, a nonallergic hyperproliferative skin inflammatory disorder with a neurogenic component.
Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells
TLDR
Flavonol inhibition of IgE‐mediated proinflammatory mediator release from hCBMCs may be due to inhibition of intracellular calcium influx and PKC θ signaling, and may therefore be suitable for the treatment of allergic and inflammatory diseases.
Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells.
TLDR
It is established that mast cells from different sites are functionally heterogeneous not only in their response to various stimuli for histamine secretion, but also in their responses to different pharmacologic modulators of secretion.
Chondroitin sulphate inhibits connective tissue mast cells
TLDR
Chondroitin sulphate appears to be a potent mast cell inhibitor of allergic and nonimmune stimulation with potential clinical implications.
Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice.
TLDR
A novel activity of astragalin is demonstrated and the dramatic effect of persimmon leaf extract and astrgalin on atopic dermatitis-model mice is demonstrated.
Mast cells and inflammation.
TLDR
The role of mast cells in inflammatory reactions of diverse origin, such as delayed type hypersensitivity, atopy, immune complex-mediated inflammation and innate immune responses are focused on.
Azelastine Inhibits Secretion of IL-6, TNF-α and IL-8 as well as NF-κB Activation and Intracellular Calcium Ion Levels in Normal Human Mast Cells
TLDR
Zelastine inhibited hCBMC secretion of IL-6, TNF-α and IL-8, possibly by inhibiting intracellular Ca2+ ions and NF-ĸB activation, and may be helpful in treating allergic inflammation.
Differential release of mast cell mediators and the pathogenesis of inflammation
TLDR
Understanding this process could help develop mast cell inhibitors of selective mediator release with novel therapeutic applications, as it appears to involve de novo synthesis of mediators, such as interleukin‐6 and vascular endothelial growth factor, with release through secretory vesicles similar to those in synaptic transmission.
...
...